Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-01 Sale | 2023-02-03 5:09 pm | Aclaris Therapeutics Inc. | ACRS | Walker Neal Director | 30,000 | $16.66 | $499,923 | 1,175,763 (Direct) | View |
| 2023-01-03 Sale | 2023-01-04 6:20 pm | Aclaris Therapeutics Inc. | ACRS | Walker Neal Director | 40,000 | $15.11 | $604,556 | 1,205,763 (Direct) | View |
| 2022-12-15 Sale | 2022-12-16 4:57 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 5,000 | $15.88 | $79,412 | 96,579 (Indirect Direct) | View |
| 2022-11-10 Sale | 2022-11-14 4:51 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 53,926 | $17.05 | $919,589 | 434,455 (Indirect Direct) | View |
| 2022-10-24 Sale | 2022-10-26 7:09 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 41,174 | $17.01 | $700,355 | 488,381 (Indirect Direct) | View |
| 2022-10-17 Sale | 2022-10-19 4:49 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 52,037 | $16.57 | $862,109 | 529,555 (Indirect Direct) | View |
| 2022-10-17 Sale | 2022-10-19 4:45 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 5,000 | $15.98 | $79,908 | 101,579 (Indirect Direct) | View |
| 2022-10-07 Sale | 2022-10-11 4:35 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 7,324 | $16.16 | $118,349 | 581,592 (Indirect Direct) | View |
| 2022-10-04 Sale | 2022-10-06 5:58 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 45,539 | $16.45 | $749,002 | 588,916 (Indirect Direct) | View |
| 2022-06-17 Sale | 2022-06-21 4:57 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 19,565 | $15.14 | $296,269 | 634,455 (Indirect Direct) | View |
| 2022-04-21 Sale | 2022-04-25 5:13 pm | Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO | 70,000 | $15.15 | $1,060,701 | 1,245,763 (Direct) | View |
| 2022-04-18 Sale | 2022-04-20 5:06 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 30,000 | $16.28 | $488,298 | 106,579 (Indirect Direct) | View |
| 2022-03-11 Sale | 2022-03-14 4:58 pm | Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO | 56,303 | $15.91 | $896,045 | 1,315,763 (Direct) | View |
| 2022-03-10 Sale | 2022-03-14 4:56 pm | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 12,823 | $15.55 | $199,335 | 201,883 (Direct) | View |
| 2022-03-10 Sale | 2022-03-14 4:53 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 27,165 | $15.71 | $426,803 | 136,579 (Indirect Direct) | View |
| 2022-02-09 Sale | 2022-02-11 4:22 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 383 | $12.68 | $4,857 | 87,494 (Indirect Direct) | View |
| 2022-02-09 Sale | 2022-02-11 4:18 pm | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 1,388 | $12.66 | $17,568 | 172,359 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 4:15 pm | Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO | 3,595 | $12.66 | $45,513 | 1,239,387 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-01 Option Award | 2023-02-03 5:07 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:04 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 486,000 | $0 | 486,000 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-03 5:01 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 11,250 | $0 | 180,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:01 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer | 135,000 | $0 | 180,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:58 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Cawkwell Gail Chief Medical Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:55 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-11-08 Gift | 2023-01-20 5:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 4,000 | $0 | 9,856 (Direct) | View |
| 2023-01-01 Ownership | 2023-01-06 4:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer | 0 | $0 | 82,175 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-02 5:10 pm | N/A 2032-07-31 | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and COO | 280,100 | $0 | 280,100 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-05 5:01 pm | N/A 2032-06-30 | Aclaris Therapeutics Inc. | ACRS | Cawkwell Gail Chief Medical Officer | 270,000 | $0 | 270,000 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 5:36 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 3,356 | $0 | 674,277 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:36 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 20,257 | $0 | 674,277 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 5:33 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 3,356 | $0 | 39,822 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:33 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director | 20,257 | $0 | 39,822 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 5:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 3,356 | $0 | 34,113 (Direct) | View |
| 2022-06-02 Gift | 2022-06-06 5:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 709 | $0 | 34,113 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:30 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director | 20,257 | $0 | 34,113 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 5:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 3,356 | $0 | 47,504 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:27 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 20,257 | $0 | 47,504 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 5:24 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 3,356 | $0 | 23,613 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:24 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director | 20,257 | $0 | 23,613 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 5:21 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 3,356 | $0 | 54,454 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:21 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 20,257 | $0 | 54,454 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 5:18 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 3,356 | $0 | 39,822 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:18 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director | 20,257 | $0 | 39,822 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-06 5:15 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 3,356 | $0 | 28,051 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:15 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director | 20,257 | $0 | 28,051 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-03 6:11 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 76,250 | $0 | 549,294 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:11 pm | N/A 2032-02-29 | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 196,800 | $0 | 549,294 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-03 6:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 42,347 | $0 | 481,451 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:08 pm | N/A 2032-02-29 | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 199,500 | $0 | 481,451 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-03 6:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO | 132,679 | $0 | 1,991,649 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:04 pm | N/A 2032-02-29 | Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO | 432,100 | $0 | 1,991,649 (Direct) | View |